Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection

Overview of attention for article published in Journal of the American Society of Nephrology, March 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 22 news stories from 21 outlets.

NEW YORK – Bio-Techne aims to leverage a recently announced collaboration with Thermo Fisher Scientific to progress Exosome…

NEW YORK – Bio-Techne aims to leverage a recent collaboration with Thermo Fisher Scientific to progress its Exosome Diagnostics…

NEW YORK ─ Bio-Techne expects its acquisition of molecular diagnostics firm Asuragen will soon contribute valuable expertise…

MINNEAPOLIS, March 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 18 additional news stories.